Studies how axial spondyloarthritis changes over time in Chinese patients
Follows people with axial spondyloarthritis to track changes in disease activity and function.
Plain-language title generated from the registry record
Registry title: The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
Key facts
- Where
- Beijing, ChinaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with axial spondyloarthritis. It follows how the disease changes over time.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- Axial spondyloarthritis diagnosed by the Assessment of Spondyloarthritis International Society (ASAS) classification criteria.
Main reasons for not taking part
- Severe, unstable medical conditions that may interfere with the study assessments, such as end-stage renal disease (eGFR < 30 mL/min/1.73m²), severe cardiovascular disease, or active malignancy
- Schizophrenia, other psychotic disorders, severe cognitive impairment, or epilepsy with recurrent uncontrolled seizures that may impair consent or follow-up
- Pregnant or lactating women
Read by machine on 9 November 2026.
Where in China
- China-Japan Friendship HospitalBeijing, ChinaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- China-Japan Friendship Hospital
- Trial code
- NCT06844643
- Record updated
- 13 April 2026
- Original description
An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.Read full original descriptionShow less
The Disease Progression of Chinese Axial Spondyloarthritis in a Real-word Cohort Study
An observational, ambispective cohort to learn about the disease progression of axial spondyloarthritis (axSpA) according to the changes from baseline in measures of disease activity, function, and imaging.
Inclusion: Patients aged 18 years or older; Diagnosis of axial spondyloarthritis (axSpA) according to the Assessment of Spondyloarthritis International Society (ASAS) classification criteria.
Exclusion: Current diagnosis of schizophrenia, other psychotic disorders, severe cognitive impairment, or epilepsy with recurrent uncontrolled seizures, which, in the opinion of the investigator, may impair the ability to provide informed consent or comply with follow-up visits; Presence of severe, unstable medical conditions that may interfere with the study assessments, including but not limited to:; End-stage renal disease (eGFR < 30 mL/min/1.73m²) Severe cardiovascular disease Active malignancy or malignancy requiring ongoing treatment; Pregnant or lactating women.